Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interferons and interferon inducers in cancer treatment.

× No keyword cloud information.

11 in total

1. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.

Authors: A Kehlen; B Göhring; J Langner; D Riemann
Journal: Clin Exp Immunol Date: 1998-02 Impact factor: 4.330

Review 2. Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma.

Authors: Bryden Considine; Michael E Hurwitz
Journal: Curr Oncol Rep Date: 2019-03-08 Impact factor: 5.075

3. Interferon-alpha-induced acute renal allograft rejection.

Authors: M Magnone; J L Holley; R Shapiro; V Scantlebury; J McCauley; M Jordan; C Vivas; T Starzl; J P Johnson
Journal: Transplantation Date: 1995-04-15 Impact factor: 4.939

4. A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients.

Authors: F Boue; Z Pastran; M Spielmann; T Le Chevalier; R Subirana; D Sevin; C Paoletti; M Brandely; M F Avril; H Sancho-Garnier
Journal: Cancer Immunol Immunother Date: 1990 Impact factor: 6.968

5. Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors.

Authors: G Gasparini; S Dal Fior; F Pozza; G A Panizzoni; S Favretto; D D Von Hoff
Journal: Invest New Drugs Date: 1991-08 Impact factor: 3.850

6. Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.

Authors: M Sivanandham; S D Scoggin; N Tanaka; M K Wallack
Journal: Cancer Immunol Immunother Date: 1994-04 Impact factor: 6.968

Interferons and interferon inducers in cancer treatment.

1. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.

Review 2. Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma.

3. Interferon-alpha-induced acute renal allograft rejection.

4. A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients.

5. Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors.

6. Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.

Review 7. CpG DNA: a pathogenic factor in systemic lupus erythematosus?

8. Clinical results and immunologic effects of a mixed bacterial vaccine in cancer patients.

Review 9. The clinical potential of interleukin-2.

Review 10. Biologic response modifiers in gynecologic malignancies.